Burkholderia pseudomallei endophthalmitis

Journal of Clinical Microbiology

Volumn 45, Issue 12, 2007, Pages 4073-4074

  Chen, Kuan Jen ^a,b   Sun, Ming Hui ^a   Hou, Chiun Ho ^a   Sun, Chi Chin ^a,b   Chen, Tun Lu ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTIZOXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; VANCOMYCIN;

ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BLURRED VISION; BURKHOLDERIA PSEUDOMALLEI; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; ENDOPHTHALMITIS; HUMAN; LABORATORY TEST; MALE; OPHTHALMOSCOPY; PATHOGENESIS; PRIORITY JOURNAL; THORAX RADIOGRAPHY; URINARY TRACT INFECTION; VISUAL ACUITY;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; ENDOPHTHALMITIS; HUMANS; MALE; MELIOIDOSIS; MIDDLE AGED;

BURKHOLDERIA PSEUDOMALLEI; NEGIBACTERIA;

EID: 37249010126     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01467-07     Document Type: Article

References (10)

1. Ashdown, L. R., R. W. Johnson, J. M. Koehler, and C. A. Cooney. 1989. Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis. J. Infect. Dis. 160:253-260.
2. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
3. Chetchotisakd, P., S. Porramatikul, P. Mootsikapun, S. Anunnatsiri, and B. Thinkhamrop. 2001. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Clin. Infect. Dis. 33:29-34.
4. Dance, D. A. 2002. Melioidosis. Curr. Opin. Infect. Dis. 15:127-132.
5. Dance, D. A., V. Wuthiekanun, W. Chaowagul, and N. J. White. 1989. The antimicrobial susceptibility of Pseudomonas pseudomallei: emergence of resistance in vitro and during treatment. J. Antimicrob. Chemother. 24:295-309.
6. Simpson, A. J. H., Y. Suputtamongkol, M. D. Smith, et al. 1999. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin. Infect. Dis. 29:381-387.
7. Siripanthong, S., S. Teerapantuwat, W. Prugsanusak, Y. Suputtamongkol, P. Viriyasithavat, W. Chaowagul, D. A. Dance, and N. J. White. 1991. Corneal ulcer caused by Pseudomonas pseudomallei: report of three cases. Rev. Infect. Dis. 13:335-337.
8. Suputtamongkol, Y., W. Chaowagul, P. Chetchotisakd, N. Lertpatanasuwun, S. Intaranongpai, T. Ruchutrakool, D. Budhsarawong, P. Mootsikapun, V. Wuthiekanun, N. Teerawatasook, and A. Lulitanond. 1999. Risk factors for melioidosis and bacteremic melioidosis. Clin. Infect. Dis. 29:408-413.
9. White, N. J. 2003. Melioidosis. Lancet 361:1715-1722.
10. Yang, I. H., J. J. Lee, J. W. Liu, and M. C. Teng. 2006. Melioidosis with endophthalmitis. Arch. Ophthalmol. 124:1501-1502.